in this issue
Regions :: North America :: U.S.
Omnova beats estimates despite net income decline
June 27, 2013 | Vincent Valk
Omnova’s fiscal second-quarter net income declined 58.6% year-on-year (YOY), to $2.9 million, on sales down 11.9%, to $270.8 million. Adjusted earnings from continuing operations, excluding restructuring and refinancing costs, totaled $7.1 million, or 16 cts/share, down 14.5% YOY but ahead of analysts’ consensus of 15 cts/share, as reported by Thomson Reuters. Omnova’s fiscal second-quarter ended on 31 May. "We have made a number of structural improvements that we expect will contribute to improved results during the remainder of the year...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee